Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Price

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Head & Neck|September 21, 2022
Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancerLinda X Yin, David M Routman, Courtney N Day, et al.
International Forum of Allergy & Rhinology|April 6, 2022
Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patientsRyan A McMillan, Jamie J Van Gompel, Michael J Link, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2022
Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal CancerKatharine Price, Kathryn M Van Abel, Eric J Moore, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|March 28, 2016
High-grade transformation of acinic cell carcinoma: an inadequately treated entity?Ashish V Chintakuntlawar, Wonwoo Shon, Michele Erickson-Johnson, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 23, 2021
Disease Profile and Oncologic Outcomes After Delayed Diagnosis of Human Papillomavirus-Associated Oropharyngeal CancerLinda X Yin, Emily E Karp, Anna Elias, et al.
The Laryngoscope|July 19, 2022
Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell CarcinomaEmily E Karp, Linda X Yin, Thomas Jamie O'Byrne, et al.
American Journal of Otolaryngology|September 11, 2021
The role of total parotidectomy in high-grade parotid malignancy: A multisurgeon retrospective reviewEmily E Karp, Joaquin J Garcia, Stephen A Chan, et al.
Head & Neck|September 24, 2020
Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapyEric J Moore, Kathryn M Van Abel, David M Routman, et al.
Oral Oncology|January 29, 2014
Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinomaJessica L Geiger, Ahmed F Lazim, Francis J Walsh, et al.
Oral Oncology|November 23, 2021
Correlation between radiographic and pathologic lymph node involvement and extranodal extension via CT and PET in HPV-associated oropharyngeal cancerRoman O Kowalchuk, Kathryn M Van Abel, Linda X Yin, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Head & Neck|September 21, 2022
Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancerLinda X Yin, David M Routman, Courtney N Day, et al.
International Forum of Allergy & Rhinology|April 6, 2022
Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patientsRyan A McMillan, Jamie J Van Gompel, Michael J Link, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2022
Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal CancerKatharine Price, Kathryn M Van Abel, Eric J Moore, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|March 28, 2016
High-grade transformation of acinic cell carcinoma: an inadequately treated entity?Ashish V Chintakuntlawar, Wonwoo Shon, Michele Erickson-Johnson, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 23, 2021
Disease Profile and Oncologic Outcomes After Delayed Diagnosis of Human Papillomavirus-Associated Oropharyngeal CancerLinda X Yin, Emily E Karp, Anna Elias, et al.
The Laryngoscope|July 19, 2022
Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell CarcinomaEmily E Karp, Linda X Yin, Thomas Jamie O'Byrne, et al.
American Journal of Otolaryngology|September 11, 2021
The role of total parotidectomy in high-grade parotid malignancy: A multisurgeon retrospective reviewEmily E Karp, Joaquin J Garcia, Stephen A Chan, et al.
Head & Neck|September 24, 2020
Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapyEric J Moore, Kathryn M Van Abel, David M Routman, et al.
Oral Oncology|January 29, 2014
Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinomaJessica L Geiger, Ahmed F Lazim, Francis J Walsh, et al.
Oral Oncology|November 23, 2021
Correlation between radiographic and pathologic lymph node involvement and extranodal extension via CT and PET in HPV-associated oropharyngeal cancerRoman O Kowalchuk, Kathryn M Van Abel, Linda X Yin, et al.
Pageof 15